Usefulness of SBA-15 mesoporous ceramics as a delivery system for vancomycin, rifampicin and linezolid: A preliminary report

International Journal of Antimicrobial Agents

Volumn 40, Issue 3, 2012, Pages 252-256

  Molina Manso, Diana ^a   Manzano, Miguel ^b,c   Doadrio, Juan Carlos ^b   Del Prado, Gema ^a   Ortiz Pérez, Alberto ^a   Vallet Regí, María ^b,c   Gómez Barrena, Enrique ^d   Esteban, Jaime ^a  

^a UAM)   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Antimicrobial; Biofilm; Bone infection; Ceramic structure; Drug delivery

Indexed keywords

BIOMATERIAL; LINEZOLID; MESOPOROUS CERAMIC; RIFAMPICIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ADSORPTION; ANTIBACTERIAL ACTIVITY; ARTICLE; BIOASSAY; CONTROLLED STUDY; DRUG CONCENTRATION; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG RELEASE; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ACETAMIDES; ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; BIOLOGICAL ASSAY; CERAMICS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; MICROCOCCACEAE; OXAZOLIDINONES; RIFAMPIN; SILICON DIOXIDE; VANCOMYCIN;

EID: 84864589040     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.05.013     Document Type: Article

References (35)

1. I.M. Smith, O.M. Austin, and A.G. Batchelor The treatment of chronic osteomyelitis: a 10 year audit J Plast Reconstr Aesthet Surg 59 2006 11 15
2. J.T. Mader, M. Ortiz, and J.H. Calhoun Osteomyelitis R.K. Root, F. Waldvogel, L. Corey, W.E. Stamm, Clinical infectious diseases 1999 Oxford University Press New York, NY 741 756
3. J.H. Calhoun, and M.M. Manring Adult osteomyelitis Infect Dis Clin North Am 19 2005 765 786 (Pubitemid 41627489)
4. J.W. Costerton The biofilm primer 2007 Springer-Verlag Berlin, Germany
5. R.A. Brady, J.H. Calhoun, J.G. Leid, and M.E. Shirtliff Infections of orthopaedic implants and devices M.E. Shirtliff, J.G. Leid, The role of biofilms in device-related infections 2009 Springer Berlin, Germany 15 55
6. N. Hoiby, T. Bjarnsholt, M. Givskov, S. Molin, and O. Ciofu Antibiotic resistance of bacterial biofilms Int J Antimicrob Agents 35 2010 322 332
7. M. Vallet-Regi Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering Chemistry 12 2006 5934 5943 (Pubitemid 44231020)
8. J. Esteban, and J. Cordero-Ampuero Treatment of prosthetic osteoarticular infections Expert Opin Pharmacother 12 2011 899 912
9. M. Vallet-Regi, F. Balas, and D. Arcos Mesoporous materials for drug delivery Angew Chem Int Ed Engl 46 2007 7548 7558 (Pubitemid 47556998)
10. M. Vallet-Regi, M. Colilla, and B. Gonzalez Medical applications of organic-inorganic hybrid materials within the field of silica-based bioceramics Chem Soc Rev 40 2011 596 607
11. D. Lozano, M. Manzano, J.C. Doadrio, A.J. Salinas, M. Vallet-Regi, and E. Gomez-Barrena Osteostatin-loaded bioceramics stimulate osteoblastic growth and differentiation Acta Biomater 6 2010 797 803
12. C.G. Trejo, D. Lozano, M. Manzano, J.C. Doadrio, A.J. Salinas, and S. Dapia The osteoinductive properties of mesoporous silicate coated with osteostatin in a rabbit femur cavity defect model Biomaterials 31 2010 8564 8573
13. I. Izquierdo-Barba, M. Vallet-Regi, N. Kupferschmidt, O. Terasaki, A. Schmidtchen, and M. Malmsten Incorporation of antimicrobial compounds in mesoporous silica film monolith Biomaterials 30 2009 5729 5736
14. Z. Li, K. Su, B. Cheng, and Y. Deng Organically modified MCM-type material preparation and its usage in controlled amoxicillin delivery J Colloid Interface Sci 342 2010 607 613
15. J. Lu, M. Liong, Z. Li, J.I. Zink, and F. Tamanoi Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals Small 6 2010 1794 1805
16. D. Zhao, Q. Huo, J. Feng, B. Chmelka, and G. Stucky Nonionic triblock and star diblock copolymer and oligomeric surfactant syntheses of highly ordered, hydrothermally stable, mesoporous silica structures J Am Chem Soc 120 1998 6024 6036 (Pubitemid 28306987)
17. F. Balas, M. Manzano, M. Colilla, and M. Vallet-Regi l-Trp adsorption into silica mesoporous materials to promote bone formation Acta Biomater 4 2008 514 522
18. A. Nieto, F. Balas, M. Colilla, M. Manzano, and M. Vallet-Regi Functionalization degree of SBA-15 as key factor to modulate sodium alendronate dosage Microporous Mesoporous Mater 116 2008 4 13
19. R.A. Brady, J.G. Leid, J.H. Calhoun, J.W. Costerton, and M.E. Shirtliff Osteomyelitis and the role of biofilms in chronic infection FEMS Immunol Med Microbiol 52 2008 13 22
20. E.S. Darley, and A.P. MacGowan Antibiotic treatment of Gram-positive bone and joint infections J Antimicrob Chemother 53 2004 928 935 (Pubitemid 38811422)
21. C. Ruef Epidemiology and clinical impact of glycopeptide resistance in Staphylococcus aureus Infection 32 2004 315 327 (Pubitemid 40104674)
22. S.J. van Hal, T.P. Lodise, and D.L. Paterson The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis Clin Infect Dis 54 2012 755 771
23. R.C. Moellering Linezolid: the first oxazolidinone antimicrobial Ann Intern Med 138 2003 135 142
24. L.V. Silva, M.T. Araujo, K.R. Santos, and A.P. Nunes Evaluation of the synergistic potential of vancomycin combined with other antimicrobial agents against methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus spp. strains Mem Inst Oswaldo Cruz 106 2011 44 50
25. B.T. Tsuji, and M.J. Rybak Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin Diagn Microbiol Infect Dis 54 2006 73 77 (Pubitemid 41815191)
26. P. Vergidis, M.S. Rouse, G. Euba, M.J. Karau, S.M. Schmidt, and J.N. Mandrekar Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis Antimicrob Agents Chemother 55 2011 1182 1186
27. G. Lewis Properties of antibiotic-loaded acrylic bone cements for use in cemented arthroplasties: a state-of-the-art review J Biomed Mater Res B Appl Biomater 89 2009 558 574
28. C.L. Nelson The current status of material used for depot delivery of drugs Clin Orthop Relat Res 427 2004 72 78 (Pubitemid 39362834)
29. M. Vallet-Regi, F. Balas, M. Colilla, and M. Manzano Drug confinement and delivery in ceramic implants Drug Metab Lett 1 2007 37 40
30. M. Vallet-Regi, J.C. Doadrio, A.L. Doadrio, I. Izquierdo-Barba, and J. Perez-Pariente Hexagonal ordered mesoporous material as a matrix for the controlled release of amoxicillin Solid State Ionics 172 2004 435 439
31. A.L. Doadrio, E.M.B. Sousa, J.C. Doadrio, J.P. Pariente, I. Izquierdo-Barba, and M. Vallet-Regi Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery J Control Release 97 2004 125 132 (Pubitemid 38624515)
32. J.C. Doadrio, E.M.B. Sousa, I. Izquierdo-Barba, A.L. Doadrio, J. Perez-Pariente, and M. Vallet-Regi Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern J Mater Chem 16 2006 462 466 (Pubitemid 43324441)
33. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 1.3, January 5, 2011. Basel, Switzerland: EUCAST; 2011. http://www.eucast.org/fileadmin/src/ media/PDFs/EUCAST-files/Disk-test-documents/EUCAST-breakpoints-v1.3-pdf.pdf [accessed 01.06.12].
34. S. Aslam Effect of antibacterials on biofilms Am J Infect Control 36 2008 S175.e9-11
35. K.B. Gattringer, M. Suchomel, M. Eder, A.M. Lassnigg, W. Graninger, and E. Presterl Time-dependent effects of rifampicin on staphylococcal biofilms Int J Artif Organs 33 2010 621 626